Table 2.
Antibiotic susceptibility results of the selected multidrug resistant (MDR) organisms.
| Bacterium | Susceptibility to prescribed antibiotics* |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aminog lycosides |
Beta-lactams |
Cephalosporins |
Fluoroquinolones |
Glyco peptides |
Macro lides |
Linc osa mides |
Sulfonamides |
Synthetics |
|||||||||||||
| Ac | Ge | Ak | Am | Ox | P | Pit | Ctr | Cf | Of | Le | Nx | Gt | Tei | Va | E | Az | Cd | Cot | Ch | Lz | |
| E. faecalis | R | R | R | R | R | R | R | R | R | MS | R | MS | R | R | R | R | S | S | R | MS | R |
| S. aureus | R | R | R | R | R | R | R | R | R | R | R | R | R | MS | R | S | R | MS | MS | R | S |
| A. baumannii | R | R | R | MS | ND | R | R | R | R | R | R | MS | S | R | ND | R | R | ND | S | S | S |
| C. freundii | R | R | R | R | ND | R | R | R | R | R | R | R | MS | MS | ND | R | MS | ND | R | R | S |
| E. aerogenes | R | R | R | R | ND | R | R | MS | S | S | R | R | R | R | ND | R | MS | ND | S | R | S |
| E. coli | R | R | S | R | ND | R | S | S | R | R | R | R | R | S | ND | R | MS | ND | R | R | S |
| K. pneumoniae | S | R | R | R | ND | R | R | MS | MS | R | R | S | S | R | ND | MS | R | ND | S | S | R |
| P. mirabilis | R | R | R | S | ND | MS | S | MS | R | R | S | R | R | R | ND | R | R | ND | R | MS | S |
| P. aeruginosa | R | R | MS | R | ND | R | R | R | R | R | R | R | MS | R | ND | R | R | ND | R | R | S |
*
Antibiotics (μg/disc) = Ac, amikacin 30; Ak, amoxyclav 30; Am, ampicillin 10; Az, azithromycin 15; Cd, clindamycin 2; Cf, cefpodoxime 10; Ch, chloramphenicol 30; Cot, co-trimoxazole 25; Ctr, ceftriaxone 30; E, erythromycin 15; Ge, gentamicin 10; Gt, gatifloxacin 5; Le, levofloxacin 5; Lz, linezolid 30; Of, ofloxacin 5; Ox, oxacillin 1; P, penicillin 10; Pit, piperacillin/tazobactam 100/10; Nx, norfloxacin 10; Tei, teichoplanin 5; Va, vancomycin 30.
MS, moderately sensitive; R, resistant; S, sensitive.